During the past decade, NZZ BORMED s.r.o. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "NZZ BORMED s.r.o." are "Arthritis, Rheumatoid" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "NZZ BORMED s.r.o." in a lesser frequency.

Most popular intervention types in "NZZ BORMED s.r.o." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Eslicarbazepine Acetate" (1 trials), "PH-797804" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "NZZ BORMED s.r.o." are 2 trials for "All" genders.

Currently, there are NaN active trials in "NZZ BORMED s.r.o.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in NZZ BORMED s.r.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NZZ BORMED s.r.o., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".